Lindbrook Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,032
| Closed | -$3.14K | – | 2970 |
|
|
2024
Q4 | $3.14K | Buy |
1,032
+398
| +63% | +$1.21K | ﹤0.01% | 2161 |
|
|
2024
Q3 | $3.29K | Hold |
634
| – | – | ﹤0.01% | 2180 |
|
|
2024
Q2 | $1.63K | Buy |
634
+546
| +620% | +$1.4K | ﹤0.01% | 2403 |
|
|
2024
Q1 | $433 | Sell |
88
-35
| -28% | -$172 | ﹤0.01% | 2531 |
|
|
2023
Q4 | $1.08K | Sell |
123
-151
| -55% | -$1.33K | ﹤0.01% | 2448 |
|
|
2023
Q3 | $3.14K | Buy |
274
+143
| +109% | +$1.64K | ﹤0.01% | 1964 |
|
|
2023
Q2 | $3.32K | Hold |
131
| – | – | ﹤0.01% | 1974 |
|
|
2023
Q1 | $4.22K | Sell |
131
-60
| -31% | -$1.93K | ﹤0.01% | 1920 |
|
|
2022
Q4 | $3.53K | Hold |
191
| – | – | ﹤0.01% | 1982 |
|
|
2022
Q3 | $5K | Buy |
191
+30
| +19% | +$785 | ﹤0.01% | 1707 |
|
|
2022
Q2 | $2K | Hold |
161
| – | – | ﹤0.01% | 2089 |
|
|
2022
Q1 | $3K | Buy |
161
+37
| +30% | +$689 | ﹤0.01% | 1901 |
|
|
2021
Q4 | $2K | Buy |
124
+36
| +41% | +$581 | ﹤0.01% | 1843 |
|
|
2021
Q3 | $2K | Hold |
88
| – | – | ﹤0.01% | 1638 |
|
|
2021
Q2 | $3K | Hold |
88
| – | – | ﹤0.01% | 1524 |
|
|
2021
Q1 | $2K | Hold |
88
| – | – | ﹤0.01% | 1626 |
|
|
2020
Q4 | $2K | Buy |
+88
| New | +$2K | ﹤0.01% | 1531 |
|